| Abstract: | Conditions for keeping busulphan lethally treated rats alive by transplantation of bone marrow cells from syngeneic donors are described. After busulphan treatment of the donor rats with a dose which only reduces the colony forming units (CFU's) in the marrow (assayed by the spleen colony technique) to half the normal numbers, at least 100 times as many cells from these treated donors, compared to untreated rats, are required to produce an equivalent increase in survival of busulphan lethally treated recipients. In contrast, aminochlorambucil, despite producing a marked fall in bone marrow cellularity, has no effect on the number of CFU/femur, yet the marrow from these aminochlorambucil treated donors is no more effective in increasing the survival of busulphan lethally treated recipients than untreated marrow. Theories which may explain this apparent discrepancy and evidence which it affords on the mode of action of busulphan are discussed. |
